Cargando…
State‐of‐the‐art therapies for Rett syndrome
Rett syndrome (RTT) is an X‐linked neurogenetic disorder caused by mutations of the MECP2 (methyl‐CpG‐binding protein 2) gene. Over two decades of work established MeCP2 as a protein with pivotal roles in the regulation of the epigenome, neuronal physiology, synaptic maintenance, and behaviour. Give...
Autores principales: | Panayotis, Nicolas, Ehinger, Yann, Felix, Marie Solenne, Roux, Jean‐Christophe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087176/ https://www.ncbi.nlm.nih.gov/pubmed/36056801 http://dx.doi.org/10.1111/dmcn.15383 |
Ejemplares similares
-
Rett syndrome from bench to bedside: recent advances
por: Ehinger, Yann, et al.
Publicado: (2018) -
Analysis of Astroglial Secretomic Profile in the Mecp2-Deficient Male Mouse Model of Rett Syndrome
por: Ehinger, Yann, et al.
Publicado: (2021) -
Rett syndrome: think outside the (skull) box
por: Borloz, Emilie, et al.
Publicado: (2021) -
Advanced genetic therapies for the treatment of Rett syndrome: state of the art and future perspectives
por: Palmieri, Michela, et al.
Publicado: (2023) -
Reflections on the Constraints and Opportunities in Therapy in Rett Syndrome
por: Kerr, Alison M.
Publicado: (2006)